Graphics Report

ABI on R&D Spending: ”An important effort in planning for fiscal 2005, which began on July 1, was to rebalance R&D programs by focusing on a smaller number of projects that met rigorous financial and market analyses. These projects are primarily in the areas of functional genomics and mass spectrometry, although we have decided to increase investments in DNA sequencing.”

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.